
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Grass never grew under her feet. She steadily rose to the top from the ranks of her industry. Now one of a handful of executive vice-presidents on the chairman's own management team, she co-directs the most important unit in the Pharmacia corporation, prescription pharmaceuticals, holding the title of president in that business.
over 25 years ago
Policy: Task Mastersover 25 years ago
Friends of Complexityover 25 years ago
Under Federal Fireover 25 years ago
Task Force: Enter the Fixersover 25 years ago
The Next Y2Kover 25 years ago
Political Science





